Can it help with gut health
Phase II Clinical Data Jastreboff 2023 (NEJM) reported 24.2% bodyweight reduction at 48 weeks - the largest effect size published for any metabolic peptide in clinical trials
This advancement will deepen our understanding of fatty acid metabolism and gut microbiota, providing new possibilities for the prevention, diagnosis, and personalized treatment of diseases
G.PhamT.FanE.BrochardL.EstebanA.et al (2016)
The drugs were identified by an earlier SILC-funded study that, over the past 18 months, examined over 5,400 blood proteins from 1,028 participants with and without long COVID and found 13 common biological pathways for the progression of the disease
Its also one of the more affordable options, but it requires more frequent administration